Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 12Unknown 2Terminated 2Recruiting 1No longer available 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Anemia, Refractory, with Excess of Blasts 5Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 3Leukemia, Myelomonocytic, Chronic 3Hematologic Neoplasms 3Graft vs Host Disease 3Recurrence 2Neuroblastoma 2Neoplasms 2Neoplasm, Residual 2Myelodysplastic-Myeloproliferative Diseases 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hodgkin Disease 2beta-Thalassemia 1Primary Myelofibrosis 1Neurofibromatosis 1 1Metabolic Diseases 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid 1

Interventions

pegaspargase 2Positron-Emission Tomography 2fludarabine 1Radiotherapy 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Etoposide 1Busulfan 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Extranodal NK-T-Cell × Busulfan × Clear all
NCT02859402 2022-08-18

RRTCLAlloSCT

Keimyung University Dongsan Medical Center

Phase 2 Recruiting
34 enrolled
Lymphoid

Recurrence, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡